Jane Huang $BGNE SEC Form 4 Insider Trading

Jane Huang has filed a total of 68 insider trades in $BGNE since 2021. Their most recent trade was a sale of 300 shares, made on Dec 14, 2021. Their largest trade was a sale of 8,177 shares, made on Jul 15, 2021. We estimate that they now own 160,055 shares of $BGNE, worth an estimated $0.

Insider Trading at $BGNE

There have been a total of 527 insider trades reported at $BGNE since 2021, with 165,529 shares purchased and 6.7 million shares sold. The most active insider traders in $BGNE stock have been John Oyler, Jane Huang, and Xiaobin Wu. The most recent trade was a sale of 4,425 shares reported by Xiaodong Wang (None), made on Nov 26, 2024.

$BGNE Executives and Stock Owners with Insider Trades

• John Oyler, Chief Executive Officer

• Jane Huang, CMO, Hematology

• Xiaobin Wu, President, COO & GM China

• Lai Wang, Global Head of R&D

• Julia Aijun Wang, Chief Financial Officer

• Chan Henry Lee, SVP, General Counsel

• Howard Liang, CFO & Chief Strategy Officer

• Titus B. Ball, Principal Accounting Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.